Overground Gait Training With a Wearable Robot in Children With Cerebral Palsy: A Randomized Clinical Trial.

A team of researchers in South Korea tested whether a wearable robotic exoskeleton could help children with cerebral palsy walk better. They recruited 90 children across five rehabilitation centres and split them into two groups. One group received 18 sessions of robot-assisted gait training over six weeks, while the other group received standard physical therapy for the same duration and number of sessions.

Children were measured on their gross motor function, balance, walking distance, and gait quality at the end of training and again four weeks later. The group using the wearable robot showed greater improvements in overall motor function and gait pattern compared to those doing standard therapy alone. The differences were relatively small but showed up consistently across several measures.

Researchers wanted to see whether a robotic suit that helps children with cerebral palsy walk could work better than traditional therapy alone. The robot works by providing assistance to the legs as a child walks overground, adjusting the amount of help based on what the child needs.

In this study, children who used the robot alongside therapy improved somewhat more in their ability to walk, their balance, and the quality of their walking pattern than children who only had regular therapy. These improvements remained visible even a month after the training ended.

The gains were modest rather than dramatic, but they showed up on multiple measures of how children moved and managed daily activities. The study involved children with varying levels of motor difficulty, so results may not apply equally to all children with cerebral palsy.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This randomised controlled trial compared six weeks of overground robot-assisted gait training (RAGT) with an untethered, torque-assisted exoskeleton against standard physical therapy in 78 children with cerebral palsy (GMFCS II-IV). The RAGT group showed statistically significant between-group advantages on the GMFM-88 total score (difference of 2.64 points), GMFM-E, GMFM-66, and PEDI-CAT responsibility domain, suggesting modest gains in gross motor function and reported independence in daily tasks.

At four-week follow-up, the RAGT group demonstrated greater improvements in balance control and Gait Deviation Index compared to controls. The magnitude of these differences was small, and it remains unclear whether they represent clinically meaningful change in children's functional walking or daily participation.

The abstract does not detail dropout reasons, fidelity of the control intervention, or how results varied across the GMFCS severity spectrum, which would help contextualise these findings for different clinical populations.